Insider Buy/Sell Details for the Healthcare Sector — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1586)
Heartflow, Inc. (HTFL)
Rogers Campbell — Chief Medical Officer
Shares
65,153
Price
$24.49
Total Value
$1.60M
Shares Held After
76,034
% of Holdings
46.1%
Biogen Inc. (BIIB)
Murphy Nicole — Head of Pharm Ops and Tech
Shares
3
Price
$195.03
Total Value
$585.11
Shares Held After
19,611
% of Holdings
0.0%
OCULAR THERAPEUTIX, INC (OCUL)
Waheed Nadia — Chief Medical Officer
Shares
7,863
Price
$9.04
Total Value
$71.08K
Shares Held After
318,417
% of Holdings
2.4%
JOINT Corp (JYNT)
JOBSON CHARLES E — 10% Owner
Shares
15,397
Price
$8.50
Total Value
$130.87K
Shares Held After
1,645,294
% of Holdings
0.9%
GLOBUS MEDICAL INC (GMED)
Huller Kelly — EVP, GC, Corporate Secretary
Shares
10,000
Price
$87.67
Total Value
$876.70K
Shares Held After
0
% of Holdings
100.0%
DEXCOM INC (DXCM)
Heller Bridgette P — Director
Shares
1,012
Price
$68.01
Total Value
$68.83K
Shares Held After
26,019
% of Holdings
3.7%
Anzu Special Acquisition Corp I (ANZU)
Lucas Brent T. — Director
Shares
62,500
Price
$0.40
Total Value
$25.00K
Shares Held After
297,090
% of Holdings
21.0%
Anzu Special Acquisition Corp I (ANZU)
BRYNELSEN CHARLES — Director
Shares
1,000,000
Price
$0.40
Total Value
$400.00K
Shares Held After
1,050,000
% of Holdings
95.2%
Anzu Special Acquisition Corp I (ANZU)
Kantor Susan — Director
Shares
96,150
Price
$0.40
Total Value
$38.46K
Shares Held After
174,037
% of Holdings
55.2%
Anzu Special Acquisition Corp I (ANZU)
Potashnick Robert — Interim CFO
Shares
212,500
Price
$0.40
Total Value
$85.00K
Shares Held After
212,500
% of Holdings
100.0%
Anzu Special Acquisition Corp I (ANZU)
Patel Mona Chetan — Director
Shares
312,500
Price
$0.40
Total Value
$125.00K
Shares Held After
332,500
% of Holdings
94.0%
Climb Bio, Inc. (CLYM)
Thomas Stephen Basil — Director
Shares
90,000
Price
$5.23
Total Value
$470.99K
Shares Held After
214,657
% of Holdings
29.5%
ZIMMER BIOMET HOLDINGS, INC. (ZBH)
Yi Sang — Group President, Asia Pacific
Shares
1,000
Price
$96.49
Total Value
$96.49K
Shares Held After
17,670
% of Holdings
5.4%
ANI PHARMACEUTICALS INC (ANIP)
Mutz Christopher — HEAD OF RARE DISEASE
Shares
7,032
Price
$76.55
Total Value
$538.30K
Shares Held After
92,566
% of Holdings
7.1%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
3,500
Price
$50.23
Total Value
$175.79K
Shares Held After
306,788
% of Holdings
1.1%
EKSO BIONICS HOLDINGS, INC. (EKSO)
ASHER DANIEL — 10% Owner
Shares
30,124
Price
$9.69
Total Value
$291.84K
Shares Held After
231,600
% of Holdings
13.0%
EKSO BIONICS HOLDINGS, INC. (EKSO)
ASHER DANIEL — 10% Owner
Shares
8,908
Price
$9.18
Total Value
$81.81K
Shares Held After
201,476
% of Holdings
4.4%
Anzu Special Acquisition Corp I (ANZU)
TAYLOR GLEN A — 10% Owner
Shares
18,750,000
Price
$0.40
Total Value
$7.50M
Shares Held After
21,703,607
% of Holdings
86.4%
Entera Bio Ltd. (ENTX)
Rubin Steven D — Director
Shares
5,000
Price
$1.49
Total Value
$7.45K
Shares Held After
15,000
% of Holdings
33.3%
ZIVO Bioscience, Inc. (ZIVO)
STROME MARK E — 10% Owner
Shares
20,000
Price
$9.77
Total Value
$195.40K
Shares Held After
472,942
% of Holdings
4.2%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
275,000
Price
$26.76
Total Value
$7.36M
Shares Held After
15,503,113
% of Holdings
1.7%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
150,000
Price
$26.72
Total Value
$4.01M
Shares Held After
15,778,113
% of Holdings
0.9%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
275,000
Price
$26.76
Total Value
$7.36M
Shares Held After
15,503,113
% of Holdings
1.7%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
150,000
Price
$26.72
Total Value
$4.01M
Shares Held After
15,778,113
% of Holdings
0.9%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
275,000
Price
$26.76
Total Value
$7.36M
Shares Held After
15,503,113
% of Holdings
1.7%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
150,000
Price
$26.72
Total Value
$4.01M
Shares Held After
15,778,113
% of Holdings
0.9%
Palisade Bio, Inc. (PALI)
Finley John David — Director
Shares
3,896
Price
$1.75
Total Value
$6.82K
Shares Held After
27,353
% of Holdings
12.5%
Palisade Bio, Inc. (PALI)
Jones Mitchell Lawrence — Chief Medical Officer
Shares
1,989
Price
$1.75
Total Value
$3.48K
Shares Held After
13,263
% of Holdings
13.0%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
521
Price
$29.64
Total Value
$15.44K
Shares Held After
50,437
% of Holdings
1.0%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
5,828
Price
$28.94
Total Value
$168.63K
Shares Held After
50,958
% of Holdings
10.3%
Edwards Lifesciences Corp (EW)
Zovighian Bernard J — Director
Shares
19,898
Price
$76.61
Total Value
$1.52M
Shares Held After
83,896
% of Holdings
19.2%
Edwards Lifesciences Corp (EW)
Zovighian Bernard J — Director
Shares
2,532
Price
$77.13
Total Value
$195.29K
Shares Held After
103,794
% of Holdings
2.4%
Cullinan Therapeutics, Inc. (CGEM)
Michaelson Jennifer — Chief Scientific Officer
Shares
416
Price
$12.03
Total Value
$5.00K
Shares Held After
128,219
% of Holdings
0.3%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
5,000
Price
$26.50
Total Value
$132.50K
Shares Held After
15,700
% of Holdings
31.8%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
5,700
Price
$24.34
Total Value
$138.74K
Shares Held After
10,700
% of Holdings
53.3%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
5,000
Price
$23.77
Total Value
$118.85K
Shares Held After
5,000
% of Holdings
100.0%
Twist Bioscience Corp (TWST)
Laponis Adam — Chief Financial Officer
Shares
7,000
Price
$50.00
Total Value
$350.00K
Shares Held After
130,031
% of Holdings
5.1%
Tyra Biosciences, Inc. (TYRA)
Bensen Daniel — Chief Discovery Officer
Shares
5,872
Price
$33.37
Total Value
$195.93K
Shares Held After
146,981
% of Holdings
3.8%
Tyra Biosciences, Inc. (TYRA)
Bensen Daniel — Chief Discovery Officer
Shares
2,128
Price
$31.50
Total Value
$67.04K
Shares Held After
152,853
% of Holdings
1.4%
Hinge Health, Inc. (HNGE)
Perez Daniel Antonio — Director
Shares
166,665
Price
$40.26
Total Value
$6.71M
Shares Held After
0
% of Holdings
100.0%
Neuraxis, INC (NRXS)
Hannasch Brian — 10% Owner
Shares
40,000
Price
$4.92
Total Value
$196.80K
Shares Held After
1,211,522
% of Holdings
3.3%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
3,354
Price
$15.70
Total Value
$52.66K
Shares Held After
428,286
% of Holdings
0.8%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
546
Price
$23.86
Total Value
$13.03K
Shares Held After
651,112
% of Holdings
0.1%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
547
Price
$23.86
Total Value
$13.05K
Shares Held After
651,114
% of Holdings
0.1%
LABCORP HOLDINGS INC. (LH)
Meltzer Jonathan C — EVP, Operations
Shares
87
Price
$290.42
Total Value
$25.27K
Shares Held After
2,782
% of Holdings
3.0%
ONCOLYTICS BIOTECH INC (ONCY)
Andrews Patricia S — Director
Shares
35,400
Price
$0.86
Total Value
$30.29K
Shares Held After
78,128
% of Holdings
45.3%
ONCOLYTICS BIOTECH INC (ONCY)
Hagerman Allison — VP, Product Development
Shares
10,000
Price
$0.83
Total Value
$8.30K
Shares Held After
115,059
% of Holdings
8.7%
ONCOLYTICS BIOTECH INC (ONCY)
Seizinger Bernd R. — Director
Shares
40,000
Price
$0.85
Total Value
$33.86K
Shares Held After
566,991
% of Holdings
7.1%
ONCOLYTICS BIOTECH INC (ONCY)
Look Kirk — Chief Financial Officer
Shares
12,000
Price
$0.84
Total Value
$10.10K
Shares Held After
287,515
% of Holdings
4.2%
ONCOLYTICS BIOTECH INC (ONCY)
Heineman Thomas Charles — Chief Medical Officer
Shares
12,132
Price
$0.83
Total Value
$10.03K
Shares Held After
282,818
% of Holdings
4.3%
Showing 901–950 of 1586 transactions (page 19 of 32)